For the week ending October 5, the number of people applying for unemployment insurance in the country jumped by 66,000 to 374,000, according to the Department of Labor. About half of the claims came from California��here computer issues half delayed processing of older claims but about 25% of the increase reflected applications from employees at government contractors.
Federal workers who have been furloughed by the government shutdown are eligible for unemployment benefits, but those figures won't be reflected in the government data until next week. Still, Jason Furman, chairman of the White House Council of Economic Advisers, said that the new data suggests that the government shutdown��long with uncertainty about whether Congress will vote to raise the country's debt limit set to hit on Oct. 17��re having a "substantial impact" on private sector confidence.
Top Healthcare Equipment Stocks To Watch Right Now: Network Exploration Ltd (NET)
Network Exploration Ltd. is an exploration and development-stage company. The Company�� principal business activities include the exploration of minerals in its mineral properties. It focuses on base and precious metal properties in North and South America. Its activities include the process of exploring its mineral properties, reviewing and subsequently acquiring mineral properties and conducting exploration programs to determine whether these properties contain ore reserves that are recoverable. The Picha copper-silver project is located within the Tertiary Volcanic Arc of Southern Peru. The Pistala project is located east of the NW-SE trending Incapquio fault system in the Department of Tacna, Southern Peru. The Company is in the business of mineral exploration in Canada, Chile and Peru. Network Exploration Chile Limitada is its wholly owned subsidiary. Advisors' Opinion:- [By Holly LaFon]
The MSCI World Index (Net) is a free float-adjusted market capitalization weighted index that is designed to measure the global equity market performance of developed markets. This benchmark calculates reinvested dividends net of withholding taxes using Luxembourg tax rates. This index is unmanaged and investors cannot invest directly in this index.
- [By Holly LaFon]
The MSCI World ex U.S. Small Cap Index (Net) is a free float-adjusted market capitalization index that is designed to measure global developed market equity performance, excluding the U.S. The MSCI Small Cap Indices target 40% of the eligible Small Cap universe within each industry group, within each country. MSCI defines the Small Cap universe as all listed securities that have a market capitalization in the range of USD200-1,500 million. This benchmark calculates reinvested dividends net of withholding taxes using Luxembourg tax rates. This index is unmanaged and investors cannot invest directly in this index.
- [By Damian Illia]
Although the company is overly relying on Afrezza, there is to say that MannKind has inked some deals in the recent past. These were primarily aimed to furthering its pipeline development but with less risk and with less research and development expenditure directly for the firm. In November, 2012 it signed a license agreement with Colby Pharmaceutical Company granting the latter exclusive rights to its early stage cancer program. Currently, the firm is also looking for partners regarding Afrezza. Last year in July, it entered one with Deerfield that ensured financing worth $160 million for MannKind. Also, in October 2012, the company raised $86 million (net) through the issuance of shares and has almost $120 million left under its credit facility. This has removed some concerned about a financial crisis in the company, although it hasn't done so throughly.
Best Managed Healthcare Companies To Buy For 2014: Energold Drilling Corp (EGDFF.PK)
Energold Drilling Corp. provides, directly and through its subsidiaries, contract diamond drilling services for parties principally in Mexico, the Caribbean, Central America, South America, Africa and Asia. The Company, through its subsidiary, designs and manufactures specialty/customized drilling rigs and associated equipment for water well, mineral exploration and geotechnical drilling companies. It, through its subsidiary, also provides drilling and other services to the energy sector in Canada and the United States. It has five segments: Drilling Mexico, the Caribbean, and Central America; Drilling South America; Drilling Africa, Asia and Other; Drilling Canada (Corporate); Manufacturing, and Energy. On January 14, 2011 the Company acquired Dando Drilling International Ltd. In April 2013, the Company�� Dando International Drilling Ltd announced that it has established a wholly owned subsidiary, Dando Drilling Services Ltd. Advisors' Opinion:- [By Itinerant]
Following a period of rampant growth in 2010 and 2011 Energold Drilling Corp (EGDFF.PK) has struggled to remain profitable throughout 2012 and into 2013. The general decline in the resource sector has left its mark on margins and contract volume. The company has maintained a robust balance sheet and can survive further hardship if necessary.
Best Managed Healthcare Companies To Buy For 2014: Global Links Corp (GLCO)
Global Links Corp. (Global Links) is engaged in real estate acquisitions and development, real estate information services and international housing projects. The Company owns approximately 996 undeveloped residential lots in the Valle Vista Subdivision. This land consists of residential lots that have not yet been developed. The Company's office building comprises 9,300 square feet, which is acquired as an empty shell, in June 2004, and completed tenant improvements in October 2004. As at December 31, 2005, the Sunset Office Building is wholly occupied. The Company occupies 15% of the building; the remaining 85% is occupied by Southwest Title Company. In August 2013, Global Links Corp. announced that the formation of a wholly owned subsidiary named Domain Micro Homes.
During the year ended December 31, 2002, the Company decided to pursue the business of marketing electronic transactions by offering a suite of electronic products and proceeded to establish relationships with various companies that provide such products and others that specialize in the marketing of these products. During the year ended December 31, 2003, Global Links transferred all of the assets and liabilities relating to the business of marketing electronic transactions to its wholly owned subsidiary, Global Links Card Services, Inc. (GLCS). In December 2004, the Company sold all of its interests in GLCS to an unrelated corporation. Also during the year ended December 31, 2003, the Company merged with Capitol Group Holding Corporation and in addition to the marketing of electronic transactions products, the Company entered the business of real estate acquisitions and development, real estate information services and international housing projects.
Advisors' Opinion:- [By Peter Graham]
Small cap stocks Green Endeavors Inc (OTCMKTS: GRNE), Global Links Corporation (OTCMKTS: GLCO) and Vitamin Blue Inc (OTCBB: VTMB) were all making noticeable moves at the end of last week. On Friday, Green Endeavors Inc rose 8.11% and Global Links Corporation rose 13.96% while Vitamin Blue Inc fell 10%. Of course, small cap OTC stocks making large single digit or double digit moves in either direction aren�� all that unusual. Moreover, all of these small caps have been the subject of paid promotions. With that in mind, here is a closer look at all three to help you decide on an investing or trading strategy:
Best Managed Healthcare Companies To Buy For 2014: TESARO Inc (TSRO)
TESARO, Inc. (TESARO), incorporated in March 2010, is a development-stage, oncology-focused biopharmaceutical company for cancer patients. The Company focuses on rolapitant and TSR-011 product. The Company�� marketed products and product candidates in development treat cancer through non-specific damage to cellular components or alter cell metabolism or internal repair mechanisms to the demise of cancer cells.
Rolapitant
Rolapitant is a potent and long-acting neurokinin-1, or NK-1, receptor antagonist is in Phase III clinical trials for the prevention of chemotherapy induced nausea and vomiting (CINV). It is in Phase III clinical trials. CINV, if not prevented by prophylaxis, has the potential to afflict up to 90% or more of cancer patients undergoing chemotherapy, depending upon the type of chemotherapy administered the dosing schedule of the chemotherapy, and the patients' age and gender, among other predisposing factors. Prolonged nausea and vomiting may result in unwanted weight loss, dehydration and malnutrition, as well as hospitalization. The Company has in-licensed the rights to rolapitant from OPKO Health, Inc.
TSR-011
TSR-011 is an orally available ALK inhibitor in preclinical development. ALK is known to be involved in certain types of cancers, including subsets of NSCLC, neuroblastoma and lymphoma. For patients in these subsets, the ALK gene is fused to an activating partner or contains point mutations, resulting in constitutive activation of ALK and the growth of cancer cells and tumor development. Inhibition of ALK in these cancer cells results in cell death and tumor growth inhibition or regression. In August 2011, the United States Food and Drug Administration approved the first ALK inhibitor, developed by Pfizer Inc., Xalkori (crizotinib), which was approved for the treatment of patients with locally advanced or metastatic NSCLC that are ALK positive.
The Company competes with GlaxoSmithKline plc, Roche Holding Ltd! . and Sanofi S.A.
Advisors' Opinion:- [By Brian Orelli]
Tesaro (NASDAQ: TSRO ) is also up today after announcing that it established a partnership with clinicians to run the phase 3 development of its PARP inhibitor, niraparib. The trial will enroll about 300 breast cancer patients with BRCA mutations, comparing niraparib to investigators' choice of other breast cancer treatments.
- [By Brian Pacampara]
Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, biopharmaceutical company TESARO (NASDAQ: TSRO ) has received the dreaded one-star ranking.
- [By Jake L'Ecuyer]
Equities Trading UP
Tesaro (NASDAQ: TSRO) shares shot up 18.28 percent to $28.40 after the company reported successful primary and secondary endpoints in final Phase 3 trial for rolapitant. - [By Jake L'Ecuyer]
Equities Trading UP
Tesaro (NASDAQ: TSRO) shares shot up 20.78 percent to $29.00 after the company reported successful primary and secondary endpoints in final Phase 3 trial for rolapitant.
No comments:
Post a Comment